{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:02:33Z","timestamp":1780761753884,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1245\/s10434-026-19545-w","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:26:28Z","timestamp":1775075188000},"page":"6787-6800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neoadjuvant Oxaliplatin and Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: CT Features of Chemotherapy-Associated Liver Injury and Postoperative Complications"],"prefix":"10.1245","volume":"33","author":[{"given":"Farha","family":"Tessier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Codjia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Sauvanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vilgrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Dioguardi Burgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Beaufrere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Sartoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"19545_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163:386-402.e1. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.056.","journal-title":"Gastroenterology"},{"key":"19545_CR2","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC Trial. J Clin Oncol Off J Am Soc Clin Oncol. 2022;40:1220\u201330. https:\/\/doi.org\/10.1200\/JCO.21.02233.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"19545_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-018-4663-4","volume":"18","author":"L Schwarz","year":"2018","unstructured":"Schwarz L, Vernerey D, Bachet J-B, Tuech J-J, Portales F, Michel P, Cunha AS. Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy: a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study). BMC Cancer. 2018;18:762. https:\/\/doi.org\/10.1186\/s12885-018-4663-4.","journal-title":"BMC Cancer"},{"issue":"25","key":"19545_CR4","doi-asserted-by":"publisher","first-page":"00004","DOI":"10.1016\/j.annonc.2024.12.015","volume":"S0923\u20137534","author":"E Rangelova","year":"2025","unstructured":"Rangelova E, Stoop TF, van Ramshorst TM, Ali M, van Bodegraven EA, Javed A. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Ann Oncol. 2025;S0923\u20137534(25):00004\u201313. https:\/\/doi.org\/10.1016\/j.annonc.2024.12.015.","journal-title":"Ann Oncol."},{"key":"19545_CR5","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1007\/s00261-019-02193-y","volume":"44","author":"F Vernuccio","year":"2019","unstructured":"Vernuccio F, DioguardiBurgio M, Barbiera F, Cusm\u00e0 S, Badalamenti G, Midiri M, et al. CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol. 2019;44:3312\u201324. https:\/\/doi.org\/10.1007\/s00261-019-02193-y.","journal-title":"Abdom Radiol."},{"key":"19545_CR6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1148\/radiol.2015141749","volume":"276","author":"NY Han","year":"2015","unstructured":"Han NY, Park BJ, Kim MJ, Sung DJ, Cho SB. Hepatic parenchymal heterogeneity on contrast-enhanced CT scans following oxaliplatin-based chemotherapy: natural history and association with clinical evidence of sinusoidal obstruction syndrome. Radiology. 2015;276:766\u201374. https:\/\/doi.org\/10.1148\/radiol.2015141749.","journal-title":"Radiology"},{"key":"19545_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.acra.2005.02.010","volume":"12","author":"K Miyake","year":"2005","unstructured":"Miyake K, Hayakawa K, Nishino M, Morimoto T, Mukaihara S. Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer. Acad Radiol. 2005;12:722\u20137. https:\/\/doi.org\/10.1016\/j.acra.2005.02.010.","journal-title":"Acad Radiol."},{"key":"19545_CR8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1038\/bjc.1998.333","volume":"77","author":"P Peppercorn","year":"1998","unstructured":"Peppercorn P, Reznek R, Wilson P, Slevin M, Gupta R. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer. 1998;77:2008\u201311. https:\/\/doi.org\/10.1038\/bjc.1998.333.","journal-title":"Br J Cancer"},{"key":"19545_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/hpb.12047","volume":"15","author":"C Hubert","year":"2013","unstructured":"Hubert C, Sempoux C, Humblet Y, van den Eynde M, Zech F, Leclercq I, Gigot J-F. Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab. HPB. 2013;15:858\u201364. https:\/\/doi.org\/10.1111\/hpb.12047.","journal-title":"HPB"},{"key":"19545_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002454","volume":"95","author":"S Park","year":"2016","unstructured":"Park S, Kim HY, Kim H, Park JH, Kim JH, Kim KH, et al. Changes in noninvasive liver fibrosis indices and spleen size during chemotherapy: potential markers for oxaliplatin-induced sinusoidal obstruction syndrome. Medicine (Baltimore). 2016;95:e2454. https:\/\/doi.org\/10.1097\/MD.0000000000002454.","journal-title":"Medicine (Baltimore)"},{"key":"19545_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejrad.2017.06.025","volume":"94","author":"S Cayet","year":"2017","unstructured":"Cayet S, Pasco J, Dujardin F, Besson M, Orain I, De Muret A, et al. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: radio-pathological correlation. Eur J Radiol. 2017;94:180\u201390. https:\/\/doi.org\/10.1016\/j.ejrad.2017.06.025.","journal-title":"Eur J Radiol."},{"key":"19545_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/TCRM.S150968","volume":"14","author":"A El Chediak","year":"2018","unstructured":"El Chediak A, Haydar AA, Hakim A, Massih SA, Hilal L, Mukherji D, et al. Increase in spleen volume as a predictor of oxaliplatin toxicity. Ther Clin Risk Manag. 2018;14:653\u20137. https:\/\/doi.org\/10.2147\/TCRM.S150968.","journal-title":"Ther Clin Risk Manag."},{"key":"19545_CR13","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1007\/s00330-020-07683-y","volume":"31","author":"T Yoh","year":"2021","unstructured":"Yoh T, Perrot A, Beaufr\u00e8re A, Hobeika C, Sartoris R, Paradis V, et al. Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy. Eur Radiol. 2021;31:5830\u20139. https:\/\/doi.org\/10.1007\/s00330-020-07683-y.","journal-title":"Eur Radiol."},{"key":"19545_CR14","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","volume":"358","author":"JP Neoptolemos","year":"2001","unstructured":"Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. The Lancet. 2001;358:1576\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(01)06651-X.","journal-title":"The Lancet"},{"key":"19545_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267\u201377. https:\/\/doi.org\/10.1001\/jama.297.3.267.","journal-title":"JAMA"},{"key":"19545_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jso.25183","volume":"118","author":"KS Cools","year":"2018","unstructured":"Cools KS, Sanoff HK, Kim HJ, Yeh JJ, Stitzenberg KB. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy. J Surg Oncol. 2018;118:455\u201362. https:\/\/doi.org\/10.1002\/jso.25183.","journal-title":"J Surg Oncol."},{"key":"19545_CR17","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1177\/00031348221087900","volume":"88","author":"DW Hyman","year":"2022","unstructured":"Hyman DW, Almerey T, Mujkanovic A, Hammons I, Tice M, Stauffer JA. Comparing postoperative outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: neoadjuvant therapy versus surgery first approach. Am Surg. 2022;88:1868\u201374. https:\/\/doi.org\/10.1177\/00031348221087900.","journal-title":"Am Surg."},{"key":"19545_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.hpb.2021.04.027","volume":"23","author":"JC van Dongen","year":"2021","unstructured":"van Dongen JC, Wismans LV, Suurmeijer JA, Besselink MG, de Wilde RF, Groot Koerkamp B, van Eijck CHJ. The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic fistula and other surgical complications after pancreatic resection: a systematic review and meta-analysis of comparative studies. HPB. 2021;23:1321\u201331. https:\/\/doi.org\/10.1016\/j.hpb.2021.04.027.","journal-title":"HPB"},{"key":"19545_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","volume":"251","author":"O Soubrane","year":"2010","unstructured":"Soubrane O, Brouquet A, Zalinski S, Terris B, Br\u00e9zault C, Mallet V, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg. 2010;251:454\u201360. https:\/\/doi.org\/10.1097\/SLA.0b013e3181c79403.","journal-title":"Ann Surg."},{"key":"19545_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatol Baltim Md. 2006;43:1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatol Baltim Md"},{"key":"19545_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"key":"19545_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0b013e318296c732","volume":"258","author":"K Slankamenac","year":"2013","unstructured":"Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien P-A. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1\u20137. https:\/\/doi.org\/10.1097\/SLA.0b013e318296c732.","journal-title":"Ann Surg."},{"issue":"3","key":"19545_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2014.12.008","volume":"220","author":"AL Simpson","year":"2015","unstructured":"Simpson AL, Leal JN, Pugalenthi A, Allen PJ, De Matteo RP, Fong Y, et al. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. J Am Coll Surg. 2015;220(3):271\u201380. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.12.008.","journal-title":"J Am Coll Surg."},{"issue":"3","key":"19545_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2214\/AJR.17.17812","volume":"209","author":"CA Campo","year":"2017","unstructured":"Campo CA, Hernando D, Schubert T, Bookwalter CA, Pay AJV, Reeder SB. Standardized approach for ROI-based measurements of proton density fat fraction and R2* in the liver. AJR Am J Roentgenol. 2017;209(3):592\u2013603. https:\/\/doi.org\/10.2214\/AJR.17.17812.","journal-title":"AJR Am J Roentgenol."},{"issue":"2","key":"19545_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1148\/radiol.2021204288","volume":"301","author":"J Starekova","year":"2021","unstructured":"Starekova J, Hernando D, Pickhardt PJ, Reeder SB. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021;301(2):250\u201362. https:\/\/doi.org\/10.1148\/radiol.2021204288.","journal-title":"Radiology."},{"key":"19545_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","volume":"21","author":"AE Bohte","year":"2011","unstructured":"Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21:87\u201397. https:\/\/doi.org\/10.1007\/s00330-010-1905-5.","journal-title":"Eur Radiol."},{"key":"19545_CR27","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s00261-020-02519-1","volume":"45","author":"R Sartoris","year":"2020","unstructured":"Sartoris R, Lazareth M, Nivolli A, DioguardiBurgio M, Vilgrain V, Ronot M. CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria. Abdom Radiol. 2020;45:2755\u201363. https:\/\/doi.org\/10.1007\/s00261-020-02519-1.","journal-title":"Abdom Radiol."},{"issue":"46","key":"19545_CR28","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.3748\/wjg.v27.i46.7866","volume":"27","author":"L Calistri","year":"2021","unstructured":"Calistri L, Rastrelli V, Nardi C, et al. Imaging of the chemotherapy-induced hepatic damage: yellow liver, blue liver, and pseudocirrhosis. World J Gastroenterol. 2021;27(46):7866\u201393. https:\/\/doi.org\/10.3748\/wjg.v27.i46.7866.","journal-title":"World J Gastroenterol."},{"key":"19545_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdh095.","journal-title":"Ann Oncol."},{"key":"19545_CR30","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","volume":"24","author":"J-N Vauthey","year":"2006","unstructured":"Vauthey J-N, Pawlik TM, Ribero D, Wu T-T, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065\u201372. https:\/\/doi.org\/10.1200\/JCO.2005.05.3074.","journal-title":"J Clin Oncol."},{"key":"19545_CR31","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","volume":"28","author":"MJ Overman","year":"2010","unstructured":"Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, et al. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010;28:2549\u201355. https:\/\/doi.org\/10.1200\/JCO.2009.27.5701.","journal-title":"J Clin Oncol."},{"key":"19545_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/j.sult.2016.08.007","volume":"37","author":"A Furlan","year":"2016","unstructured":"Furlan A, Minervini MI, Borhani AA, DioguardiBurgio M, Tublin ME, Brancatelli G. Hepatic sinusoidal dilatation: a review of causes with imaging-pathologic correlation. Semin Ultrasound CT MRI. 2016;37:525\u201332. https:\/\/doi.org\/10.1053\/j.sult.2016.08.007.","journal-title":"Semin Ultrasound CT MRI"},{"key":"19545_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2214\/AJR.16.16514","volume":"207","author":"PJ Pickhardt","year":"2016","unstructured":"Pickhardt PJ, Malecki K, Kloke J, Lubner MG. Accuracy of liver surface nodularity quantification on MDCT as a noninvasive biomarker for staging hepatic fibrosis. Am J Roentgenol. 2016;207:1194\u20139. https:\/\/doi.org\/10.2214\/AJR.16.16514.","journal-title":"Am J Roentgenol."},{"key":"19545_CR34","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1007\/s00330-021-08436-1","volume":"32","author":"S Heo","year":"2022","unstructured":"Heo S, Kim DW, Choi SH, Kim SW, Jang JK. Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis. Eur Radiol. 2022;32:3377\u201387. https:\/\/doi.org\/10.1007\/s00330-021-08436-1.","journal-title":"Eur Radiol."},{"key":"19545_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/SLA.0000000000003223","volume":"270","author":"P S\u00e1nchez-Vel\u00e1zquez","year":"2019","unstructured":"S\u00e1nchez-Vel\u00e1zquez P, Muller X, Malleo G, Park J-S, Hwang H-K, Napoli N, et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000003223.","journal-title":"Ann Surg."},{"key":"19545_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archsurg.1991.01410310095014","volume":"126","author":"O Ishikawa","year":"1991","unstructured":"Ishikawa O. Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreatoduodenectomy. Arch Surg. 1991;126:885. https:\/\/doi.org\/10.1001\/archsurg.1991.01410310095014.","journal-title":"Arch Surg."},{"key":"19545_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/SLA.0000000000000378","volume":"260","author":"RP Merkow","year":"2014","unstructured":"Merkow RP, Bilimoria KY, Tomlinson JS, Paruch JL, Fleming JB, Talamonti MS, et al. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg. 2014;260:372\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000000378.","journal-title":"Ann Surg."},{"issue":"11","key":"19545_CR38","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1245\/s10434-022-11946-x","volume":"29","author":"G Guarneri","year":"2022","unstructured":"Guarneri G, Palumbo D, Pecorelli N, et al. The impact of CT-assessed liver steatosis on postoperative complications after pancreaticoduodenectomy for cancer. Ann Surg Oncol. 2022;29(11):7063\u201373. https:\/\/doi.org\/10.1245\/s10434-022-11946-x.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"19545_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Duarte-Rojo A, Patel K, et al. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81(2):672\u2013724. https:\/\/doi.org\/10.1097\/HEP.0000000000000843.","journal-title":"Hepatology."},{"issue":"5","key":"19545_CR40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00330-011-2349-2","volume":"22","author":"PJ Pickhardt","year":"2012","unstructured":"Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol. 2012;22(5):1075\u201382. https:\/\/doi.org\/10.1007\/s00330-011-2349-2.","journal-title":"Eur Radiol."},{"issue":"9","key":"19545_CR41","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1245\/s10434-025-17736-5","volume":"32","author":"CF Cardell","year":"2025","unstructured":"Cardell CF, Dekker EN, Katz MHG, Tzeng CD. The landmark series: neoadjuvant therapy for resectable pancreatic cancer. Ann Surg Oncol. 2025;32(9):6467\u201376. https:\/\/doi.org\/10.1245\/s10434-025-17736-5.","journal-title":"Ann Surg Oncol."},{"key":"19545_CR42","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-19056-0","author":"L Liguori","year":"2026","unstructured":"Liguori L, Ventin M, Cattaneo G, et al. Implications of homologous recombination deficiency for neoadjuvant platinum-based chemotherapy in pancreatic cancer: a narrative review. Ann Surg Oncol. 2026. https:\/\/doi.org\/10.1245\/s10434-025-19056-0.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"19545_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/SLA.0000000000006472","volume":"280","author":"N Pecorelli","year":"2024","unstructured":"Pecorelli N, Guarneri G, Di Salvo F, et al. the impact of postoperative complications on recovery of health-related quality of life and functional capacity after pancreatectomy: findings from a prospective observational study. Ann Surg. 2024;280(5):719\u201327. https:\/\/doi.org\/10.1097\/SLA.0000000000006472.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19545-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:35Z","timestamp":1780761095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19545"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19545-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}